RPS6KB1 and fragile X syndrome: Administration of TFP reduced the enhanced phosphorylation back to wild-type levels, demonstrating that S6K1 signaling is enhanced in Fmr1 knock-out hippocampal cultures, and also suggests the antipsychotic drug TFP as potential treatment for the FXS [191].